Toripalimab Combined with Concurrent Platinum-Based Chemoradiotherapy in Patients with Locally Advanced Cervical Cancer: an Open-Label, Single-Arm, Phase II Trial
BMC Cancer(2022)
Key words
Cervical cancer,Chemoradiotherapy,Immunotherapy,Immune checkpoint inhibitor,PD-L1 inhibitor,Toripalimab
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined